Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £239.60m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Form 8 (DD) - TP Group plc

27 Aug 2021 07:00

RNS Number : 9488J
Science Group PLC
27 August 2021
 

FORM 8 (DD)

 

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Science Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TP Group plc

(d) Status of person making the disclosure:

e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree)

Offeror

(e) Date dealing undertaken:

26 August 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

 

Class of relevant security:

 

1p Ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

180,400,971

23.15

(2) Cash-settled derivatives:

 

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

 

TOTAL:

180,400,971

23.15

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

1p Ordinary

Purchase

333,981

6.0p

1p Ordinary

Purchase

4,500

6.0p

1p Ordinary

Purchase

843,906

6.5p

1p Ordinary

Purchase

1,330,000

6.5p

 

(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

N/A

N/A

 

N/A

N/A

N/A

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

N/A

N/A

N/A

N/A

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

 

N/A

N/A

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

N/A

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

N/A

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

27 August 2021

Contact name:

Sarah Cole

Group Legal Counsel & Company Secretary

Telephone number:

01223 875 200

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DCCSEMFWMEFSEDA
Date   Source Headline
8th Mar 20197:00 amRNSTransaction in Own Shares
5th Mar 20197:00 amRNSAudited results for year ended 31 December 2018
26th Feb 20197:00 amRNSNotice of Preliminary Results
21st Feb 20193:15 pmRNSTR1: Notification of Major Interest in Shares
20th Feb 20197:00 amRNSExtended Bank Facilities
24th Jan 20197:00 amRNSCorporate Strategic Review
19th Dec 20187:00 amRNSTransaction in Own Shares
18th Dec 20187:00 amRNSTR1: Notification of Major Interest in Shares
17th Dec 20182:33 pmRNSForm 8.3 - Science Group plc
14th Dec 201812:13 pmRNSForm 8.3 - Science Group plc
14th Dec 20187:00 amRNSTrading Update; Termination of Formal Sale Process
12th Dec 201812:33 pmRNSForm 8.3 - Science Group plc
7th Dec 201812:10 pmRNSForm 8.3 - Science Group plc
3rd Dec 201812:40 pmRNSForm 8.3 - Science Group plc
3rd Dec 20187:00 amRNSTreasury shares issued & Rule 2.9 announcement
30th Nov 201811:02 amRNSForm 8.3 - Science Group plc
29th Nov 201812:04 pmRNSForm 8.3 - Science Group plc
27th Nov 201810:01 amRNSForm 8.3 - Science Group plc
27th Nov 201810:00 amRNSFinance Director maternity leave
26th Nov 20182:23 pmRNSForm 8.3 - Science Group plc
21st Nov 201810:55 amGNWForm 8.3 - [Science Group plc]
21st Nov 20187:58 amRNSForm 8.5 (EPT/RI) - Science Group PLC
15th Nov 20188:56 amRNSForm 8.5 (EPT/RI) - Science Group Plc
14th Nov 20188:15 amRNSForm 8.5 (EPT/RI) - Science Group PLC
13th Nov 20187:00 amRNSTreasury shares issued & Rule 2.9 Announcement
5th Nov 20189:22 amRNSForm 8.5 (EPT/RI) - Science Group PLC
31st Oct 201810:07 amGNWForm 8.3 - Science Group Plc
30th Oct 20188:16 amRNSForm 8.5 (EPT/RI) - Science Group PLC
29th Oct 20185:24 pmRNSForm 8.3 - Science Group PLC
29th Oct 20187:00 amRNSTreasury shares issued & Rule 2.9 Announcement
24th Oct 20181:29 pmRNSForm 8.3 - Science Group plc
17th Oct 20187:00 amRNSRule 2.9 Announcement
16th Oct 20187:00 amRNSTreasury shares issued
9th Oct 20182:41 pmRNSForm 8.3 - Science Group Plc
9th Oct 20188:51 amRNSForm 8.5 (EPT/RI) - Science Group PLC
8th Oct 20182:01 pmRNSForm 8.3 - Science Group plc
2nd Oct 201810:29 amRNSForm 8.5 (EPT/RI) - Science Group PLC
26th Sep 201810:59 amRNSForm 8.3 - Science Group plc
26th Sep 20187:00 amRNSForm 8 (OPD) - Science Group plc
25th Sep 20183:24 pmRNSForm 8.3 - Science Group plc
25th Sep 20181:46 pmRNSForm 8.5 (EPT/RI) - Science Group PLC
25th Sep 20189:29 amRNSForm 8.3 - Science Group Plc
24th Sep 20185:02 pmPRNForm 8.3 - Science Group Plc
24th Sep 20183:37 pmRNSForm 8.3 - Science Group PLC
24th Sep 20181:50 pmRNSForm 8.3 - Science Group Plc
24th Sep 20181:18 pmRNSForm 8.3 - Science Group Plc
24th Sep 20188:10 amRNSForm 8.5 (EPT/RI) - Science Group PLC
21st Sep 20182:32 pmRNSForm 8.3 - Unicorn Asset Management
21st Sep 20187:01 amRNSFormal Sale Process as Part of Strategic Review
21st Sep 20187:00 amRNSCorporate Strategic Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.